Lexington, MA, United States of America

Allen T Hopper

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Allen T Hopper: Innovator in Pharmaceutical Treatments

Introduction

Allen T Hopper is a notable inventor based in Lexington, MA (US), recognized for his contributions to the field of pharmaceuticals. He holds a total of 3 patents, focusing on innovative methods for treating infections and related conditions. His work has significantly impacted the development of new therapeutic approaches.

Latest Patents

Hopper's latest patents include "Compositions and methods for treating infections," which relates to inhibitors of dihydrofolate reductase and pharmaceutical preparations thereof. This invention further explores methods of treating parasitic infections using these novel inhibitors. Another significant patent is "CDPK1 inhibitors, compositions, and methods related thereto," which focuses on inhibitors of calcium-dependent protein kinase 1 (CDPK1) and their pharmaceutical applications. This invention also addresses methods for treating parasitic infections with these innovative inhibitors.

Career Highlights

Throughout his career, Allen T Hopper has worked with prominent organizations, including Vyera Pharmaceuticals, LLC and Washington University. His experience in these institutions has allowed him to advance his research and contribute to the development of effective pharmaceutical treatments.

Collaborations

Hopper has collaborated with notable colleagues such as Stephen B Thomas and Matthew Welsch, enhancing the scope and impact of his research endeavors.

Conclusion

Allen T Hopper's innovative work in the pharmaceutical field, particularly in the treatment of infections, showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving health outcomes through research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…